Ronnie T.P. Poon
University of Hong Kong(HK)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Cancer Mechanisms and Therapy, Cholangiocarcinoma and Gallbladder Cancer Studies, Cancer, Hypoxia, and Metabolism, Liver physiology and pathology
Most-Cited Works
- → Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma(2010)1,017 cited
- → Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma(2012)986 cited
- → Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study(2013)766 cited
- → Tumor Size Predicts Vascular Invasion and Histologic Grade(2005)636 cited
- → Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study(2013)593 cited
- → Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib(2014)566 cited
- → Yes‐associated protein is an independent prognostic marker in hepatocellular carcinoma(2009)540 cited
- → Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma(2013)527 cited
- → Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma(2014)488 cited
- → Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial(2014)344 cited